Vol 6 (December 30, 2022): Mediastinum [Abstract Book for the 12th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2022)]

Abstract
AB014. Effective somatostatin analogs in a case of advanced thymoma with no uptake in the octreotide scan
Xabier Mielgo-Rubio, Susana Hernando Polo, Elisabeth Jiménez Aguilar, Clara Olier Garate, Alicia Hurtado Nuño, Diana Moreno Muñoz, Maria Virginia Sánchez Becerra, Andrea María González López, Mónica Esteban García, Teresa Robles Bermejo, Manuel Barón, Florentino Hernando Trancho, Jose Ramón Jarabo, Juan Carlos Cámara Vicario
Mediastinum  
2022;
6:
AB014  
(30 December 2022) 
PDF ABSTRACT (558) COI Form Open Access Get Permission
Abstract
AB013. Treatment of thymic oligometastastic or oligoprogressive lesions with hypofractionated radiation therapy or stereotactic body radiation therapy
Christopher B. Jackson, Andreas Rimner, Charles B. Simone II, Emily S. Lebow, James Huang, Stephanie M. Lobaugh, Zhigang Zhang, Gregory J. Riely, Michelle S. Ginsberg, Andrew M. Pagano, Jason C. Chang, Maria Mayoral, Daniel G. Gomez, Annemarie F. Shepherd
Mediastinum  
2022;
6:
AB013  
(30 December 2022) 
PDF ABSTRACT (585) COI Form Open Access Get Permission
Abstract
AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
James M. Dolezal, Wenji Guo, Christine Bestvina, Everett Vokes, Jessica Donington, Aliya Husain, Marina Chiara Garassino
Mediastinum  
2022;
6:
AB012  
(30 December 2022) 
PDF ABSTRACT (912) COI Form Open Access Get Permission
Abstract
AB011. Thymoma in patient receiving tyrosine kinase inhibitor (TKI) treatment: morphological aspects and surgical approach
Margherita Cattaneo, Lorenzo Rosso, Ilaria Righi, Giorgio A. Croci, Paolo Mendogni
Mediastinum  
2022;
6:
AB011  
(30 December 2022) 
PDF ABSTRACT (492) COI Form Open Access Get Permission
Abstract
AB010. Clinical significance of serum Cyfra 21-1 as a marker in thymic epithelial tumors
Xiuxiu Hao, Xuefei Zhang, Wentao Fang
Mediastinum  
2022;
6:
AB010  
(30 December 2022) 
PDF ABSTRACT (649) COI Form Open Access Get Permission
Abstract
AB009. Lessons learned from non-therapeutic thymectomies
Michelle Chua, Emma Cole, Ben Dunne, Phillip Antippa, Jeffrey Lai, Mark W. McCusker
Mediastinum  
2022;
6:
AB009  
(30 December 2022) 
PDF ABSTRACT (650) COI Form Open Access Get Permission
Abstract
AB008. Activated pathways of Thymic Epithelial Tumors: a RYTHMIC study
Jose Carlos Benitez, Bastien Job, Vincent Thomas de Montpréville, Juan-David Florez-Arango, Ludovic Lacroix, Patrick Saulnier, Riad Arana, Olivier Lambotte, Sacha Mussot, Olaf Mercier, Elie Fadel, Jean-Yves Scoazec, Thierry Molina, Nicolas Girard, Benjamin Besse
Mediastinum  
2022;
6:
AB008  
(30 December 2022) 
PDF ABSTRACT (829) COI Form Open Access Get Permission
Abstract
AB007. Expression of trophoblastic antigen 2 (Trop2) in thymic epithelial tumors
Vincent Yeung, Jacob Zaemes, Justin Yeh, Cardoza Giancarlo, Jaeil Ahn, Joshua Reuss, Bhaskar V. Kallakury, Stephen V. Liu, Anju Duttargi, Galam Khan, Chul Kim
Mediastinum  
2022;
6:
AB007  
(30 December 2022) 
PDF ABSTRACT (435) COI Form Open Access Get Permission
Abstract
AB006. Effectiveness of chemotherapy as the first-line treatment for thymic tumors with pleural dissemination
Xuefei Zhang, Lanting Gao, Xiuxiu Hao, Fenghao Yu, Zhitao Gu, Wentao Fang
Mediastinum  
2022;
6:
AB006  
(30 December 2022) 
PDF ABSTRACT (740) COI Form Open Access Get Permission
Abstract
AB005. Thymic carcinoma arising in a multilocular thymic cyst that previously went through complete remission after antibiotics treatment
Fenghao Yu, Ning Xu, Xuefei Zhang, Xiuxiu Hao, Zhitao Gu, Wentao Fang
Mediastinum  
2022;
6:
AB005  
(30 December 2022) 
PDF ABSTRACT (484) COI Form Open Access Get Permission
Abstract
AB004. Radiotherapy for thymic epithelial tumors: what is the optimal dose?—a systematic review
Antonio Angrisani, Ruud Houben, Florit Marcuse, Monique Hochstenbag, Jos Maessen, Dirk De Ruysscher, Stephanie Peeters
Mediastinum  
2022;
6:
AB004  
(30 December 2022) 
PDF ABSTRACT (441) COI Form Open Access Get Permission
Abstract
AB003. Benefits of proton radiotherapy in thymic epithelial tumors using the model-based approach
Stephanie T. H. Peeters, Esther Kneepkens, Florit Marcuse, Xin Zhang, Monique Hochstenbag, Jos Maessen, Dirk De Ruysscher
Mediastinum  
2022;
6:
AB003  
(30 December 2022) 
PDF ABSTRACT (356) COI Form Open Access Get Permission
Abstract
AB002. Anlotinib as salvage treatment for patients with relapsed and refractory thymic epithelial tumors
Chang-Lu Wang, Yi-Zhuo Zhao, Qin Zhang, Wan-Qin Zeng, Tian-Ying Jia, Lei Zhu, Wen-Tao Fang, Xiao-Long Fu
Mediastinum  
2022;
6:
AB002  
(30 December 2022) 
PDF ABSTRACT (309) COI Form Open Access Get Permission
Abstract
AB001. Surgical resection followed by entire hemithorax irradiation in patients with stage IVa thymoma: preliminary result of a prospective phase II study
Changlu Wang, Qin Zhang, Xiaolong Fu, Zhitao Gu, Teng Mao, Wentao Fang
Mediastinum  
2022;
6:
AB001  
(30 December 2022) 
PDF ABSTRACT (669) COI Form Open Access Get Permission

Disclosure:

The “Abstract Book for the 12th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2022)” was commissioned by the editorial office, Mediastinum without any sponsorship or funding.